Mitogenic growth factors in breast fluid obtained from healthy women: Evaluation of biological and extraneous sources of variability

Cancer Epidemiology Biomarkers and Prevention

Volumn 6, Issue 6, 1997, Pages 421-428

  Gann, Peter ^a   Chatterton, Robert ^a   Vogelsong, Kirsten ^a   Dupuis, Joséc ^a   Ellman, Allison ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; ARTICLE; BREAST CANCER; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR FLUID; FEMALE; HUMAN; NIPPLE; NORMAL HUMAN; NORMAL VALUE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RADIOIMMUNOASSAY;

ADULT; BREAST NEOPLASMS; EPIDERMAL GROWTH FACTOR; ESTRADIOL; EXUDATES AND TRANSUDATES; FEMALE; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; NIPPLES; PROGESTERONE; RADIOIMMUNOASSAY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUCTION; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 0030926213     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Dickson, R. B., and Lippman, M. E. Growth factors in breast cancer. Endocr. Rev., 16: 559-589, 1995.
2. Lippman, M. E., Dickson, R. B., Bates, S., Knabbe, C., Huff, K., Swain, S., McManaway, M., Bronzert, D., Kasid, A., and Gelmann, E. P. Autocrine and paracrine growth regulation of human breast cancer. Breast Cancer Res. Treat., 7: 59-70, 1986.
3. Paik, S., Hazan, R., Fisher, E. R., Sass, R. E., Fisher, B., Redmond, C., Schlessinger, J., Lippman, M. E., and King, C. R. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. J. Clin. Oncol., 8: 103-112, 1990.
4. Fox, S. B., Smith, K., Hollyer, J., Greenal, M., Hastrich, D., and Harris, A. L. The epidermal growth factor receptor as a prognostic marker: results of 370 patients and a review of 3009 patients. Breast Cancer Res. Treat., 29: 41-50, 1994.
5. Clarke, R., Dickson, R. B., and Lippman, M. E. Hormonal aspects of breast cancer: growth factors, drugs and stromal interactions. Crit. Rev. Oncol. Hematol., 12: 1-23, 1992.
6. Dickson, R. B., Gottardis, M. M., and Merlino, G. T. Molecular insights into breast cancer from transgenic mouse models. Bioessays, 13: 591-596, 1991.
7. Medina, D., Kittrell, F. S., Oborn, C. J., and Schwartz, M. Growth factor dependency and gene expression in preneoplastic mouse mammary epithelial cells. Cancer Res., 53: 668-674, 1993.
8. Petrakis, N. L. Nipple aspirate fluid in epidemiologic studies of breast disease. Epidemiol. Rev., 15: 188-195, 1993.
9. Rose, D. P. Hormones and growth factors in nipple aspirates from normal women and benign breast disease patients. Cancer Detect. Prev., 16:43-51, 1992.
10. Connolly, J. M., and Rose, D. P. Epidermal growth factor-like proteins in breast fluid and human milk. Life Sci., 42: 1751-1756, 1988.
11. Carpenter, G. Epidermal growth factor is a major growth-promoting agent in human milk. Science (Washington DC), 210: 198-199, 1980.
12. Ness, J. C., Sedghinasab, M., Moe, R. E., and Tapper, D. Identification of multiple proliferative growth factors in breast cyst fluid. Am. J. Surg., 766: 237-243, 1993.
13. Valenti, G., Zanardi, S., Cerruti, G., Fassio, T., Bruzzi, P., DeFranchis, V., Barreca, A., Del Monte, P., and Minuto, F. Epidermal growth factor in breast cyst fluid: relationship with intracystic cation and androgen conjugate content. Cancer Res., 48: 5860-5863, 1988.
14. Wilcosky, T. C. Criteria for selecting and evaluating markers. In: B. S. Hulka, T. C. Wilcosky, and J. D. Griffith (eds.). Biochemical Markers in Epidemiology, pp. 28-55. New York: Oxford University Press, 1990.
15. Kesaree, N., Banapurmath, C. R., Nanapurmath, S., and Shamanur, K. Treatment of inverted nipples using a disposable syringe. J. Hum. Lact., 9:27-29, 1993.
16. Bonfrer, J. M. G., Bruning, P. F., and Nooljen, W. J. A simple method for the measurement of the steroid fraction bound to sex hormone binding globulin. J. Steroid Biochem., 33: 227-231, 1989.
17. Chatterton, R. T., Haan, J. N., Jenco, J. M., and Cheesman, K. L. Radioimmunoassay of pregnanediol concentrations in early morning urine specimens for assessment of luteal function in women. Fertil. Steril., 37: 361-366, 1982.
18. Fleiss, J. L. Reliability of measurement. In: The Design and Analysis of Clinical Experiments, pp. 1-32. New York: John Wiley & Sons, 1986.
19. Good, P. Permutation Tests: A Practical Guide to Resampling Methods for Testing Hypotheses, pp. 96-97. New York: Springer-Verlag New York, Inc., 1994.
20. Diggle, P. J., Liang, K., and Zeger, S. L. In: Analysis of Longitudinal Data, p. 169. Oxford: Oxford University Press, 1994.
21. Wrensch, M. R., Petrakis, N. L., Gruenke, L. D., Ernster, V. L., Miike, R., King, E. B., and Hauck, W. W. Factors associated with obtaining nipple aspirate fluid: analysis of 1428 women and literature review. Breast Cancer Res. Treat., 15: 39-51, 1990.
22. Petrakis, N. L. Cerumen phenotype and epithelial dysplasia in nipple aspirates of breast fluid. Am. J. Phys. Anthropol., 62: 115-118, 1983.